$BIOA 4 SEC Filings

Filed On	Filing
01 Jul 2026	Form 4: Barton Shane, Principal Accounting Officer Received 39,718 shares by exercise or conversion ($263K) · Sold 42,350 shares ($1.07M) · Received 20,216 shares by exercise or conversion ($132K) · 1 more
12 Jun 2026	Form 4: Pande Vijay Satyanand, Director Granted 22,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Hemrajani Rekha, Director Granted 22,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Healy James, Director Granted 22,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Enright Patrick G, Director Granted 22,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Davidson Michael H., Director Granted 22,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Garnier Jean Pierre, Director Granted 22,000 Stock Option (Right to Buy)
24 Apr 2026	Form 4: Goldstein Dov A Md, Chief Financial Officer Received 3,542 shares by exercise or conversion ($15.5K)
03 Apr 2026	Form 4: Rubin Paul D, Chief Medical Officer Received 8,820 shares by exercise or conversion ($44.6K) · Sold 8,820 shares ($157K)
03 Mar 2026	Form 4: Rubin Paul D, Chief Medical Officer Received 7,433 shares by exercise or conversion ($35.5K) · Sold 7,433 shares ($151K)
03 Mar 2026	Form 4: Goldstein Dov A Md, Chief Financial Officer Received 3,542 shares by exercise or conversion ($15.5K)
19 Feb 2026	Form 4: Morgen Eric, Director Granted 122,500 Stock Option (Right to Buy)
19 Feb 2026	Form 4: Rubin Paul D, Chief Medical Officer Granted 110,000 Stock Option (Right to Buy)
19 Feb 2026	Form 4: Goldstein Dov A Md, Chief Financial Officer Granted 110,000 Stock Option (Right to Buy)
19 Feb 2026	Form 4: Fortney Kristen, Director Granted 330,000 Stock Option (Right to Buy)
19 Feb 2026	Form 4: Barton Shane, Principal Accounting Officer Granted 45,000 Stock Option (Right to Buy)
03 Feb 2026	Form 4: Rubin Paul D, Chief Medical Officer Received 7,433 shares by exercise or conversion ($35.5K) · Sold 7,433 shares ($139K)
03 Feb 2026	Form 4: Goldstein Dov A Md, Chief Financial Officer Received 3,541 shares by exercise or conversion ($15.5K)
21 Jan 2026	Form 4: Goldstein Dov A Md, Chief Financial Officer Received 3,542 shares by exercise or conversion ($15.5K)
15 Jan 2026	Form 4: Fortney Kristen, Director Sold 233,107 shares ($4.22M)

Comments